ECHO CE Program: Drug Testing in Opioid Use Disorder
VirtualAn interactive didactic to learn about interpretation and appropriate use of drug testing in opioid use disorder and a case presentation. Free CEs are provided.
An interactive didactic to learn about interpretation and appropriate use of drug testing in opioid use disorder and a case presentation. Free CEs are provided.
Do you have questions or need assistance for your patient navigator role? Join the Camden Coalition for monthly case reviews, discussion of navigator referral challenges, community resource mapping and other topics of interests. The inaugural event is this upcoming Friday, November 6th at 12pm. To register, click here.
Open forum featuring guest speakers to discuss medication-assisted treatment (MAT) issues and an opportunity to network!
An interactive didactic to learn how to implement and utilize drug testing methods and a case presentation. Free CEs are provided.
An interactive didactic on how to incorporate harm reduction in your opioid use disorder practice. Free CEs are provided.
Open forum featuring guest speakers to discuss medication-assisted treatment (MAT) issues and an opportunity to network!
An interactive didactic on identifying what is success and how to measure success and outcomes in your opioid use disorder practice and a case presentation. Free CEs are provided.
This session will evaluate two common models of MOUD service delivery ("Nurse Care Manager" and "Hub and Spoke") and consider appropriateness of fit; identify potential OUD patients using evidence-based screening tools and consider how screening can be integrated into current patient flow; develop an MOUD implementation plan that includes clinical, documentation/metrics, and financial considerations.
Open forum featuring guest speakers to discuss medication-assisted treatment (MAT) issues and an opportunity to network!
Join us for the next MAT Lunch Hour to network and collaborate. This MAT lunch hour will feature Peter Treitler and Jim Lloyd, research specialists from the Rutgers Institute of Health, who will be presenting data on the impact of COVID-19 on MOUD providers in New Jersey.